NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Synteract Inc. has attained the study build accreditation in Medidata’s channel partner program. With this accreditation, Synteract can now provide the full suite of Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) services to sponsors.